Sunday, March 2, 2025
spot_img

White House urges FDA to reconsider HCQ for treatment

Date:

Share post:

spot_img
spot_img

Washington: The White House has urged the US Food and Drug Administration (FDA) to reinstate its emergency use authorization (EUA) for the anti-malaria drug, hydroxychloroquine (HCQ), for COVID-19 treatment.

Weeks ago, the FDA revoked the EUA that allowed for HCQ used to treat certain hospitalized patients with COVID-19, after the agency determined that the drug was “unlikely to be effective in treating COVID-19 for the authorized uses in the EUA”, while highlighting potential serious side effects, reports Xinhua news agency.

“White House trade adviser Peter Navarro is leading a Trump administration effort to demand the FDA reverse course,” the Washington Post said in a report on Monday. “A reversal (on HCQ) would be widely seen as bending to the political will of the White House,” the Washington Post quoted Steven Joffe, a medical ethicist at the University of Pennsylvania, as saying. (IANS)

spot_img
spot_img

Related articles

Maha: One arrested in harassment case of Union Minister’s daughter, hunt on of 6 others

Muktainagar (Maharashtra), March 2 : Jalgaon Police on Sunday confirmed the arrest of one of the seven accused...

Kashmiris engage in prayers, charities in holy month of Ramzan

Srinagar, March 2 : The holy Muslim fasting month of Ramzan started in Jammu and Kashmir along with...

Chamoli avalanche: CM Dhami reaches Disaster Operations Centre, monitors search ops

Chamoli, March 2: Uttarakhand Chief Minister Pushkar Singh Dhami on Sunday visited the Disaster Operations Centre and held...

India will be at forefront of AI era, says Piyush Goyal

Mumbai, March 2: With the Modi government’s sound policies playing the role of an enabler for entrepreneurs and...